Early-TIPSS placement prevents rebleeding in high-risk patients with variceal bleeding, without improving survival

Alimentary Pharmacology and Therapeutics

Volumn 40, Issue 9, 2014, Pages 1074-1080

  Rudler, M ^a   Cluzel, P ^a   Corvec, T L ^a   Benosman, H ^a   Rousseau, G ^b   Poynard, T ^a   Thabut, D ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; OCTREOTIDE; PREDNISOLONE; PROPRANOLOL;

ADULT; ALCOHOL LIVER DISEASE; ARTICLE; BLOOD TRANSFUSION; CHILD PUGH SCORE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DOSE INCREASE; EARLY INTERVENTION; ENDOSCOPIC SURGERY; ESOPHAGUS VARICES BLEEDING; EXTERNAL VALIDITY; FEMALE; HEART FAILURE; HEMATEMESIS; HEPATIC ENCEPHALOPATHY; HIGH RISK PATIENT; HOSPITAL ADMISSION; HOSPITAL READMISSION; HUMAN; INTENSIVE CARE UNIT; INTESTINE ENDOSCOPY; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MELENA; MIDDLE AGED; MODEL FOR END STAGE LIVER DISEASE SCORE; MORTALITY; PORTAL VEIN BLOOD PRESSURE; PRESSURE GRADIENT; PROBABILITY; PROSPECTIVE STUDY; SEPSIS; SURVIVAL RATE; TIPS ENDOPROSTHESIS; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; VEIN LIGATION; ADVERSE EFFECTS; AGED; COMPLICATION; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HEMORRHAGE; PROCEDURES; RISK FACTOR; TIME; TRENDS;

AGED; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL HEMORRHAGE; HEMORRHAGE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TIME FACTORS;

EID: 84907998374     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12934     Document Type: Article

References (18)

1. D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 2006; 44: 217-31.
2. Thabut D, Rudler M, Massard J. Variceal bleeding in patients with cirrhosis: what are the unanswered questions?. Gastroenterol Clin Biol 2008; 32: 614-9.
3. Carbonell N, Pauwels A, Serfaty L, Fourdan O, Lévy VG, Poupon R. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology 2004; 40: 652-9.
4. deFranchis R; Baveno V Faculty. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol. 2010; 53: 762-8.
5. Azoulay D, Castaing D, Majno P, et al. Salvage transjugular intrahepatic portosystemic shunt for uncontrolled variceal bleeding in patients with decompensated cirrhosis. J Hepatol 2001; 35: 590-7.
6. Monescillo A, Martínez-Lagares F, Ruiz-del-Arbol L, et al. Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding. Hepatology 2004; 40: 793-801.
7. García-Pagán JC, Caca K, Bureau C, et al. (Transjugular Intrahepatic Portosystemic Shunt) Cooperative Study Group. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med 2010; 362: 2370-9.
8. Garcia-Pagán JC, Di Pascoli M, Caca K, et al. Use of early-TIPS for high-risk variceal bleeding: results of a post-RCT surveillance study. J Hepatol 2013; 58: 45-50.
9. Reverter E, Tandon P, Augustin S, et al. A MELD-based model to determine risk of mortality among patients with acute variceal bleeding. Gastroenterology 2014; 146: 412-9.
10. Al-Freah MAB, Gera A, Martini S, et al. Comparison of scoring systems and outcome of patients admitted to a liver intensive care unit of a tertiary referral centre with severe variceal bleeding. Aliment Pharmacol Ther 2014 : 39: 1286-300.
11. D'Amico G, De Franchis R; Cooperative Study Group. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology. 2003; 38: 599-612.
12. Kimer N, Krag A, Moller S, Bendtsen F, Gluud LL. Systematic review with meta-analysis: the effects of rifaximin in hepatic encephalopathy. Aliment Pharamacol Ther 2014; 40: 123-32.
13. Rabie RN, Cazzaniga M, Salerno F, Wong F. The use of E/A ratio as a predictor of outcome in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt. Am J Gastroenterol 2009; 104: 2458-66.
14. Conférence de Consensus: Complications de l'hypertension portale chez l'adulte. 04-05 Décembre 2003, Paris, France.
15. Villanueva C, Colomo A, Bosch A, et al. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med 2013; 368: 11-21.
16. Villanueva C, Ortiz J, Miñana J, et al. Somatostatin treatment and risk stratification by continuous portal pressure monitoring during acutevariceal bleeding. Gastroenterology 2001; 121: 110-7.
17. Bosch J, Thabut D, Albillos A, et al.; International Study Group on rFVIIa in UGI Hemorrhage. Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: a randomized, controlled trial. Hepatology. 2008; 47: 1604-14.
18. Rudler M, Rousseau G, Thabut D. Salvage transjugular intrahepatic portosystemic shunt followed by early transplantation in patients with Child C14-15 cirrhosis and refractory variceal bleeding: a strategy improving survival. Transpl Int 2013; 26: E50-1.